Alex joined Bristows as partner in December 2018. He is head of the regulatory team, primarily advising life sciences clients.

He has more than 20 years’ experience advising clients in the sector, having qualified as a solicitor (in Australia) in 1995 and moved to the UK in 2004. In addition to his LLB, Alex has a BSc in Human Genetics.

Alex has a commercial and pragmatic approach, in part as a result of having spent more than five years in-house, including as GC and Company Secretary of Biotech Australia.

He enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices.

Alex has advised clients in relation to more challenging issues including: genomics, cell therapies, tissue and cells requirements, borderline products, combination products, 3D printing, healthcare apps and remote diagnostics, and has been involved in the development of a number of regulatory frameworks and guidelines.

In addition to a range of contentious (judicial review) and advisory matters, he has a breadth of international experience structuring, negotiating and drafting commercial agreements.

Alex is widely published and speaks regularly at conferences. Publications include a chapter in the Law and Regulation of Medicines and one in Stem Cells in Regenerative Medicine.

Legal 500 describes Alex as “a straight-talking, commercially astute technology specialist who is always willing to take a view” and who delivers “out-of-the-box solutions”.